11月28日,国家医保局召开新闻发布会,介绍2024年国家医保药品目录调整工作,并公布新版药品目录。本次调整后,目录内药品总数将增至3159种,其中西药1765种、中成药1394种,肿瘤、慢性病、罕见病、儿童用药等领域的保障水平得到明显提升。 本次调整中,创新药企表现亮眼。先声药业的三款创新药科赛拉、恩立妥和先必新成功纳入医保目录。其中,科赛拉作为全球首个化疗前骨髓保护药物,为癌症患者提供了全新...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.